SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 228 filers reported holding SORRENTO THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.70 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $150,189 | -36.1% | 169,514 | +13.4% | 0.09% | -43.7% |
| Q3 2022 | $235,000 | +32.0% | 149,477 | +68.4% | 0.17% | +47.8% |
| Q2 2022 | $178,000 | -12.3% | 88,738 | +2.1% | 0.11% | -0.9% |
| Q1 2022 | $203,000 | -40.6% | 86,934 | +18.1% | 0.11% | -35.6% |
| Q4 2021 | $342,000 | +4.3% | 73,584 | +71.4% | 0.18% | -6.8% |
| Q3 2021 | $328,000 | -15.5% | 42,929 | +7.2% | 0.19% | -17.0% |
| Q2 2021 | $388,000 | +29.8% | 40,058 | +10.9% | 0.23% | +16.8% |
| Q1 2021 | $299,000 | +79.0% | 36,123 | +47.9% | 0.20% | +60.7% |
| Q4 2020 | $167,000 | -4.6% | 24,426 | +55.6% | 0.12% | -12.2% |
| Q3 2020 | $175,000 | +130.3% | 15,702 | +29.7% | 0.14% | +110.6% |
| Q2 2020 | $76,000 | +13.4% | 12,102 | -53.5% | 0.07% | +10.0% |
| Q1 2020 | $67,000 | -24.7% | 26,002 | +23.2% | 0.06% | -22.1% |
| Q4 2019 | $89,000 | – | 21,100 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 6,000,000 | $66,900,000 | 2.57% |
| SABBY MANAGEMENT, LLC | 606,298 | $6,760,000 | 1.01% |
| Virtus ETF Advisers LLC | 66,851 | $745,000 | 0.39% |
| Newbridge Financial Services Group, Inc. | 26,900 | $300,000 | 0.30% |
| Avidian Wealth Solutions, LLC | 330,000 | $3,680,000 | 0.28% |
| Spectrum Wealth Advisory Group, LLC | 36,692 | $422,000 | 0.27% |
| COWEN AND COMPANY, LLC | 129,200 | $1,441,000 | 0.24% |
| Cormorant Asset Management, LP | 500,000 | $5,575,000 | 0.21% |
| SYMMETRY PEAK MANAGEMENT LLC | 27,500 | $307,000 | 0.20% |
| Aristides Capital LLC | 24,302 | $271,000 | 0.19% |